- have
resistance to
multiple drugs simultaneously. Artemisinin-based
monotherapies for
malaria are
explicitly discouraged to
avoid the
problem of developing...
-
Multiple studies suggest hydrochlorothiazide could be used as
initial monotherapy in
people with
primary hypertension; however, the
decision should be...
- (Solian) –
approved in low
doses as a
monotherapy for
persistent depression Lumateperone (Caplyta) –
approved as a
monotherapy for
bipolar depression Lurasidone...
- an
antacid monotherapy arm. A
robust double-blind
clinical trial performed in 2003 by
Berman et al.
compared 30 mL of
antacid monotherapy,
antacid with...
-
supplements were
compared with 5‐aminosalicylic acid
treatment as a
monotherapy, the
likelihood of
remission was 22%
higher if
probiotics were used in...
- Food and Drug Administration, to
treat bipolar depression,
either as
monotherapy or
adjunctively with
lithium or valproate.
Generic versions were approved...
-
treatment of
schizophrenia as well as
bipolar depression, as
either monotherapy or
adjunctive therapy (with
lithium or valproate). It is
developed by...
-
effective monotherapy in
psychotic depression,
although there is
evidence that it is
ineffective for
depressive symptoms as a
monotherapy; and olanzapine/fluoxetine...
-
disorder (ADHD) and high
blood pressure.
Guanfacine is FDA-approved for
monotherapy treatment of ADHD, as well as
being used for
augmentation of
other treatments...
- well-studied and characterized. The most
common side
effects of
bicalutamide monotherapy in men
include breast tenderness,
breast growth, feminization, demasculinization...
